Richard Pazdur, a longtime Food and Drug Administration employee, would lead its center that oversees over-the-counter and ...
The Food and Drug Administration has named a longtime regulator of cancer medications to lead the agency’s drug center ...
The U.S. Food and Drug Administration said on Tuesday it appointed the agency's veteran oncology chief Richard Pazdur to ...
More Americans are injecting themselves with unapproved chemicals that are pitched as ways to build muscle, rejuvenate skin ...
Pazdur replaces former Center for Drug Evaluation and Research Director George Tidmarsh, who exited the agency earlier this ...
A gene therapy for Duchenne muscular dystrophy caused complications to the liver, prompting a review of its use for younger patients.
Opinion
Why Richard Pazdur taking over the FDA’s drug division is good for patients — and drug companies
Why naming veteran regulator Richard Pazdur to head the Food and Drug Administration’s Center for Drug Evaluation and Research is fantastic news for patients and drug companies.
The FDA says websites, including one out of Naperville, are illegally marketing unapproved and misbranded botulinum toxin products.
The bill prohibited the FDA from enforcing regulations aimed at increasing traceability of the supply chain, among other ...
Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.
The US Food and Drug Administration said Tuesday that Dr. Richard Pazdur has been named head of the Center for Drug Evaluation and Research, its largest division, which oversees the safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback